Publications by authors named "Karl-Johan Lindner"

Claim this Profile
I
Improved Medication communication and Patient involvement At Care Transitions (IMPACT-care): study protocol for a pre-post intervention trial in older hospitalised patients.
Henrik Cam, Kristin Franzon, Victoria Östman, Sofia Kälvemark Sporrong, Thomas Gerardus Hendrik Kempen, Karl-Johan Lindner

BMJ Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'You're Just Thinking About Going Home': Exploring Person-Centred Medication Communication With Older Patients at Hospital Discharge.
Henrik Cam, Kristin Franzon, Sofia Kälvemark Sporrong, Thomas Gerardus Hendrik Kempen, Cecilia Bernsten, Karl-Johan Lindner

Health Expect· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complexities of communication at hospital discharge of older patients: a qualitative study of healthcare professionals' views.
Henrik Cam, Björn Wennlöf, Ulrika Gillespie, Kristin Franzon, Elisabet I Nielsen, Karl-Johan Lindner

BMC Health Serv Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for and preventability of drug-related hospital revisits in older patients: A post-hoc analysis of a randomized clinical trial.
Thomas G H Kempen, Anton N Hedman, Nermin Hadziosmanovic, Karl-Johan Lindner, Håkan Melhus

Br J Clin Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Hospital-Based Comprehensive Medication Reviews Including Postdischarge Follow-up on Older Patients' Use of Health Care: A Cluster Randomized Clinical Trial.
Thomas G H Kempen, Maria Bertilsson, Nermin Hadziosmanovic, Karl-Johan Lindner, Håkan Melhus

JAMA Netw Open· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intervention fidelity and process outcomes of medication reviews including post-discharge follow-up in older hospitalized patients: Process evaluation of the MedBridge trial.
Thomas G H Kempen, Henrik Cam, Amanda Kälvemark, Karl-Johan Lindner, Håkan Melhus

J Clin Pharm Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Reviews Bridging Healthcare (MedBridge): Study protocol for a pragmatic cluster-randomised crossover trial.
Thomas G H Kempen, Maria Bertilsson, Karl-Johan Lindner, Johanna Sulku, Elisabet I Nielsen

Contemp Clin Trials· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
Ola Lindén, Jan Tennvall, Cecilia Hindorf, Eva Cavallin-Ståhl, Karl-Johan Lindner

Acta Oncol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis